3 free views remaining today

acute necrotizing encephalitis

Description

Acute necrotizing encephalitis (ANE) is a rare and severe form of brain disease that occurs following a viral infection. It is characterized by the rapid onset of symptoms, including:

  • Fever: A high temperature, often accompanied by other flu-like symptoms.
  • Seizures: Sudden, uncontrolled muscle contractions or convulsions.
  • Altered mental status: Changes in consciousness, such as confusion, disorientation, or coma.

The disease is typically preceded by a viral infection, and the exact pathogenesis (cause) of ANE remains unclear. However, research suggests that it may be related to an abnormal immune response to the virus, leading to inflammation and damage in the brain.

ANE can affect anyone, but most reported cases are from previously healthy children and young adults. The disease is often fatal if not treated promptly and effectively.

Symptoms of ANE:

  • Rapid onset of weakness
  • Seizures
  • Coma
  • Altered mental status
  • Fever

Causes and risk factors:

  • Viral infections, such as influenza A and B
  • Abnormal immune response to the virus
  • Genetic predisposition (in some cases)

References:

  • [1] Acute necrotizing encephalopathy (ANE) is a rare subtype of acute infectious encephalopathy, first described by Mizuguchi in 1995. [12]
  • [2] ANE is characterized by febrile illness followed by altered consciousness and seizures. [13]
  • [3] The pathologic features of the disease are necrosis and multiple symmetric lesions affecting the bilateral thalami with or without other brain involvement. [12]

Note: The above information is based on the search results provided in the context, which include descriptions from various medical sources.

Additional Characteristics

  • Acute necrotizing encephalitis (ANE) is a rare and severe form of brain disease that occurs following a viral infection.
  • The symptoms include fever, seizures, altered mental status, rapid onset of weakness, coma, and altered mental status.
  • Causes and risk factors include viral infections, abnormal immune response to the virus, and genetic predisposition in some cases.

Signs and Symptoms

Symptoms of Acute Necrotizing Encephalopathy

Acute necrotizing encephalopathy (ANE) is a rare disease characterized by brain damage that usually follows an acute febrile disease, mostly viral infections. The symptoms of ANE can vary from person to person but often include:

  • Rapid changes in consciousness: Affected individuals may experience sudden changes in their level of consciousness, ranging from mild confusion to coma [4][5].
  • Focal neurological deficits: Patients with ANE may exhibit focal neurological deficits, such as weakness or paralysis on one side of the body [6][7].
  • Seizures: Seizures are a common symptom of ANE, affecting up to 67% of patients during the acute phase [7].
  • Fever: Fever is often present in patients with ANE, particularly during the initial stages of the disease [1][3].
  • Rapid alteration in mental status: Patients may experience rapid changes in their mental status, including confusion, agitation, or altered consciousness [6][8].

Other symptoms

In addition to these primary symptoms, patients with ANE may also experience:

  • Hepatic dysfunction: Some patients may develop hepatic dysfunction, which can manifest as elevated liver enzymes or even liver failure [8].
  • Bilateral thalamic involvement: Bilateral thalamic involvement is a common feature of ANE, affecting up to 90% of patients [9].

Demographics

Acute necrotizing encephalopathy typically affects infants and young children, although some cases have been reported in adolescents and adults. The disease has been reported worldwide, with the majority of cases coming from Japan and Taiwan [12][15].

Additional Symptoms

  • Seizures
  • Focal neurological deficits
  • Rapid changes in consciousness
  • Rapid alteration in mental status
  • Bilateral thalamic involvement
  • hepatic dysfunction
  • fever

Diagnostic Tests

Diagnostic Tests for Acute Necrotizing Encephalopathy

Acute necrotizing encephalopathy (ANE) is a rare and severe brain disease that requires prompt diagnosis and treatment. The diagnostic tests for ANE are crucial in confirming the condition and guiding further management.

  • Cerebrospinal fluid (CSF) testing: Elevated protein levels and very rarely pleocytosis (increased cell count) in CSF are indicative of ANE [1]. *

Additional Diagnostic Tests

  • Cerebrospinal fluid (CSF) testing

Treatment

Treatment Options for Acute Necrotizing Encephalopathy (ANE)

Acute Necrotizing Encephalopathy (ANE) is a rare and severe condition that requires prompt medical attention. While there are no established guidelines for treating ANE, various case reports and studies have suggested potential treatment options.

  • Steroids and IVIG: Steroids, such as methylprednisolone or dexamethasone, and intravenous immunoglobulin (IVIG) are commonly used to treat ANE. These medications can help reduce inflammation and modulate the immune response [1][2].
  • Tocilizumab: Recent case reports have suggested a beneficial role for tocilizumab, an interleukin-6 receptor antagonist, in treating ANE [3]. This medication may be particularly useful as an add-on therapy to steroids and IVIG.
  • High-Dose Methylprednisolone: High-dose methylprednisolone has been associated with better outcomes in children with ANE [4].
  • IVIG, PLEX, and Tocilizumab: Case reports have shown promise with good outcomes using a combination of IVIG, plasmapheresis (PLEX), and tocilizumab [5].

Current Challenges

Despite these potential treatment options, there are currently no evidence-based guidelines for treating ANE. Randomized trials are needed to establish the most effective treatment protocols.

  • Lack of Standardization: Treatment modalities for ANE vary widely, and there is a need for standardization in clinical practice [7].
  • Limited Research: There have been no randomized trials conducted on ANE, making it challenging to determine the most effective treatments [8].

Future Directions

Further research is necessary to establish the most effective treatment protocols for ANE. This may involve conducting randomized trials and developing evidence-based guidelines.

References:

[1] Li K (2021) - Steroids and IVIG for immunomodulation therapy in ANEC

[2] Hosie PH (2023) - Early use of interleukin-6 blockade as 'add-on' immunotherapy in ANE

[3] Hosie PH (2023) - Beneficial role of tocilizumab in treating ANE

[4] Chang HP (2022) - High-Dose Methylprednisolone Therapy in Children with Acute Necrotizing Encephalopathy

[5] Fischell SZ (2023) - Case reports of patients treated with IVIG, PLEX, and tocilizumab

[7] Bashiri FA (2020) - Treatment modalities for ANE: A review

[8] Silverman A (2024) - No evidence-based guidelines currently exist for ANE

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Acute Necrotizing Encephalopathy (ANE)

Acute necrotizing encephalopathy (ANE) is a rare and severe form of encephalopathy, and its differential diagnosis can be challenging. Based on the search results

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11400
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0338418
oboInOwl#id
DOID:5222
core#notation
DOID:5222
rdf-schema#label
acute necrotizing encephalitis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_9588
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.